Table 1. Clinicopathological data for the 34 MGCTs of childhood analysed.
Sample | Histology | Histology subtype | Site | Age (years) | Gender | Stage | Outcome | EFSa (months) |
---|---|---|---|---|---|---|---|---|
1 | Germinoma | Pure | Ovary | 12 | Female | 1 | Alive | 47 |
2 | Germinoma | Pure | Ovary | 13 | Female | 3 | Alive | 46 |
3 | Germinoma | Pure | Ovary | 14 | Female | 2 | Alive | 40 |
4 | Germinoma | Pure | Ovary | 10 | Female | 1 | Relapse | 16 |
5 | Germinoma | Pure | Ovary | 6 | Female | 4 | Alive | 20 |
6 | Germinoma | Pure | Ovary | 12 | Female | 1 | Dead | 27 |
7 | Germinoma | Pure | Ovary | 12 | Female | 1 | Alive | 15 |
8 | Germinoma | Pure | Ovary | 13 | Female | 1 | Relapse | 23 |
9 | Germinoma | Pure | Brain | 16 | Male | 1 | Alive | 144 |
10 | Germinoma | Pure | Brain | 10 | Female | 1 | Dead | 14 |
11 | Germinoma | Within teratoma | Ovary | 12 | Female | 2 | Alive | 36 |
12 | Embryonal carcinoma | Pure | Metastasisb | 15 | Male | 4 | Relapse | 8 |
13 | Yolk sac tumour | Pure | Testis | 1 | Male | 1 | Alive | 51 |
14 | Yolk sac tumour | Pure | Testis | 1 | Male | 1 | Alive | 92 |
15 | Yolk sac tumour | Pure | Testis | 0 | Male | 1 | Alive | 37 |
16 | Yolk sac tumour | Pure | Testis | 4 | Male | 1 | Alive | 30 |
17 | Yolk sac tumour | Pure | Testis | 1 | Male | 1 | Alive | 14 |
18 | Yolk sac tumour | Pure | Testis | 0 | Male | 1 | Alive | 12 |
19 | Yolk sac tumour | Pure | Testis | 2 | Male | 1 | Alive | 44 |
20 | Yolk sac tumour | Pure | Ovary | 14 | Female | 4 | Alive | 78 |
21 | Yolk sac tumour | Pure | Ovary | 13 | Female | 2 | Alive | 58 |
22 | Yolk sac tumour | Pure | Ovary | 12 | Female | 1 | Alive | 28 |
23 | Yolk sac tumour | Pure | Ovary | 12 | Female | 1 | Alive | 69 |
24 | Yolk sac tumour | Pure | Ovaryc | 9 | Female | 2 | Alive | 93 |
25 | Yolk sac tumour | Pure | Ovary | 14 | Female | 1 | Relapse | 2 |
26 | Yolk sac tumour | Pure | Ovary | 13 | Female | 3 | Alive | 72 |
27 | Yolk sac tumour | Within teratoma | SCT | 2 | Female | 4 | Alive | 55 |
28 | Yolk sac tumour | Within teratoma | SCT | 3 | Female | 4 | Alive | 21 |
29 | Yolk sac tumour | Within teratoma | SCT | 0 | Female | 4 | Alive | 42 |
30 | Yolk sac tumour | Within teratoma | SCT | 1 | Male | 4 | Alive | 28 |
31 | Yolk sac tumour | Within teratoma | SCT | 1 | Male | 1 | Alive | 54 |
32 | Yolk sac tumour | Within teratoma | Brain | 12 | Male | 1 | Alive | 136 |
33 | Yolk sac tumour | Pure | Ovary | 0 | Female | 2 | Relapse | 4 |
34 | Yolk sac tumour | Pure | Vagina | 1 | Female | 2 | Alive | 43 |
EFS – Event-free survival.
Pulmonary metastasis of a testicular primary.
Contralateral streak ovary noted peri-operatively, SCT – sacrococcygeal teratoma.